List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 8 studies with search of:   "Repligen Corporation" [Exact]
Hide studies that are not seeking new volunteers.
  Hide Display Options
Display Options - choose fields to display in search results below
Rank Status Study
1 Terminated RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease
Condition: Mitochondrial Diseases
Intervention: Drug: RG2133 (2',3',5'-tri-O-acetyluridine)
2 Terminated Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction
Condition: Autism
Intervention: Drug: RG1068 (Synthetic Human Secretin)
3 Enrolling by invitation Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas
Condition: Pancreatitis
Intervention: Drug: RG1068 (synthetic human secretin)
4 Completed Synthetic Human Secretin in Children With Autism
Condition: Autism
Intervention: Drug: RG1068 (Synthetic Human Secretin)
5 Recruiting A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression
Condition: Bipolar I Depression
Interventions: Drug: RG2417;   Drug: Placebo
6 Completed Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression
Condition: Bipolar Depression
Intervention: Drug: Uridine
7 Completed Effects of RG1068 (Secretin) on Information Processing in Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Subcutaneous Secretin
8 Completed Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder
Condition: Obsessive Compulsive Disorder (OCD)
Intervention: Drug: RG1068 (Synthetic Human Secretin)

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options